JP2021522857A5 - - Google Patents
Info
- Publication number
- JP2021522857A5 JP2021522857A5 JP2021510294A JP2021510294A JP2021522857A5 JP 2021522857 A5 JP2021522857 A5 JP 2021522857A5 JP 2021510294 A JP2021510294 A JP 2021510294A JP 2021510294 A JP2021510294 A JP 2021510294A JP 2021522857 A5 JP2021522857 A5 JP 2021522857A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- recombinant soluble
- bacteriophage
- target
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862667400P | 2018-05-04 | 2018-05-04 | |
| US62/667,400 | 2018-05-04 | ||
| US201862743740P | 2018-10-10 | 2018-10-10 | |
| US62/743,740 | 2018-10-10 | ||
| US201962818066P | 2019-03-13 | 2019-03-13 | |
| US62/818,066 | 2019-03-13 | ||
| PCT/US2019/030695 WO2019213592A1 (en) | 2018-05-04 | 2019-05-03 | Methods and compositions for killing a target bacterium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522857A JP2021522857A (ja) | 2021-09-02 |
| JP2021522857A5 true JP2021522857A5 (https=) | 2022-05-13 |
Family
ID=68386731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510294A Pending JP2021522857A (ja) | 2018-05-04 | 2019-05-03 | 標的細菌を死滅させるための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US20200354690A1 (https=) |
| EP (1) | EP3788152A4 (https=) |
| JP (1) | JP2021522857A (https=) |
| KR (1) | KR20210018273A (https=) |
| CN (1) | CN112424363A (https=) |
| AU (1) | AU2019262200A1 (https=) |
| CA (1) | CA3099316A1 (https=) |
| TW (1) | TW202014519A (https=) |
| UY (1) | UY38215A (https=) |
| WO (1) | WO2019213592A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3711488A1 (en) | 2015-05-06 | 2020-09-23 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| FR3096373B1 (fr) * | 2019-05-24 | 2024-09-13 | Ifp Energies Now | Outil genetique optimisé pour modifier les bacteries |
| US20220265766A1 (en) * | 2019-07-30 | 2022-08-25 | The Regents Of The University Of California | Antimicrobial therapy through the combination of pore-forming agents and histones |
| WO2021092254A1 (en) * | 2019-11-06 | 2021-05-14 | Locus Biosciences, Inc. | Phage compositions comprising crispr-cas systems and methods of use thereof |
| US20230002761A1 (en) * | 2019-11-19 | 2023-01-05 | Benson Hill, Inc. | Anti-bacterial crispr compositions and methods |
| CA3171941A1 (en) * | 2020-03-16 | 2021-09-23 | Joseph E. Peters | Compositions and methods comprising improved guide rnas |
| WO2021195594A1 (en) * | 2020-03-26 | 2021-09-30 | San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation | Compositions and methods for treating or ameliorating infections |
| WO2021231689A1 (en) * | 2020-05-14 | 2021-11-18 | Chan Zuckerberg Biohub, Inc. | Phage-mediated delivery of genes to gut microbiome |
| GB202007943D0 (en) * | 2020-05-27 | 2020-07-08 | Snipr Biome Aps | Products & methods |
| CA3197277A1 (en) * | 2020-11-05 | 2022-05-12 | Paul GAROFOLO | Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof |
| US20240011041A1 (en) * | 2020-11-05 | 2024-01-11 | Locus Biosciences, Inc. | Phage compositions for pseudomonas comprising crispr-cas systems and methods of use thereof |
| SK289101B6 (sk) * | 2020-12-17 | 2023-08-09 | Ústav molekulárnej biológie Slovenskej akadémie vied, verejná výskumná inštitúcia | Antimikrobiálny proteín, antimikrobiálny rekombinantný proteín s lytickými vlastnosťami, expresný vektor, spôsob ich prípravy a použitie |
| WO2022235816A2 (en) * | 2021-05-05 | 2022-11-10 | Locus Biosciences, Inc. | Bacteriophage comprising type i crispr-cas systems |
| WO2022235799A2 (en) * | 2021-05-05 | 2022-11-10 | Locus Biosciences, Inc. | Phage compositions for staphylococcus comprising crispr-cas systems and methods of use thereof |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
| EP4604969A1 (en) * | 2022-10-17 | 2025-08-27 | Locus Biosciences, Inc. | Staphylococcus phage compositions and cocktails thereof |
| CN117210413B (zh) * | 2023-08-04 | 2026-04-21 | 湖北文理学院 | 纹带棒状杆菌噬菌体及其应用 |
| WO2025109112A1 (en) * | 2023-11-22 | 2025-05-30 | Centre National De La Recherche Scientifique | Engineered phagemids and methods for antibacterial peptide delivery against bacterial pathogens in particular clostridioides difficile |
| US12274722B1 (en) * | 2024-04-24 | 2025-04-15 | Phage Technology Center Gmbh | Antibiotic free treatment of mastitis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2341149T3 (en) * | 2005-08-26 | 2017-02-27 | Dupont Nutrition Biosci Aps | Use of CRISPR-associated genes (Cas) |
| CN101688241B (zh) * | 2007-03-02 | 2015-01-21 | 杜邦营养生物科学有限公司 | 具有改善的噬菌体抗性的培养物 |
| CN106536739B (zh) * | 2014-04-14 | 2021-08-03 | 内梅西斯生物有限公司 | 治疗剂 |
| HRP20200529T1 (hr) * | 2014-06-06 | 2020-09-04 | Regeneron Pharmaceuticals, Inc. | Postupci i pripravci za modificiranje ciljnog lokusa |
| CN107208070B (zh) * | 2014-11-26 | 2021-09-07 | 技术创新动力基金（以色列）有限合伙公司 | 细菌基因的靶向消除 |
| EP3711488A1 (en) * | 2015-05-06 | 2020-09-23 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| WO2016205276A1 (en) * | 2015-06-15 | 2016-12-22 | North Carolina State University | Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials |
| EP4089175A1 (en) * | 2015-10-13 | 2022-11-16 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
| US11311582B2 (en) * | 2015-11-19 | 2022-04-26 | Locus Biosciences, Inc. | Bacteriophage compositions and methods of use thereof |
| US11542466B2 (en) * | 2015-12-22 | 2023-01-03 | North Carolina State University | Methods and compositions for delivery of CRISPR based antimicrobials |
| WO2017223101A1 (en) * | 2016-06-22 | 2017-12-28 | The United States Of America As Represented By The Secretary Of The Navy | Bacteriophage compositions and methods of selection of components against specific bacteria |
| US11672839B2 (en) * | 2016-12-05 | 2023-06-13 | Technechnophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa | Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof |
| GB201710126D0 (en) * | 2017-06-25 | 2017-08-09 | Snipr Tech Ltd | Vectors & Methods |
| KR20210006344A (ko) | 2018-03-25 | 2021-01-18 | 에스엔아이피알 바이옴 에이피에스. | 미생물 감염의 치료 및 예방 |
-
2019
- 2019-05-03 CA CA3099316A patent/CA3099316A1/en active Pending
- 2019-05-03 WO PCT/US2019/030695 patent/WO2019213592A1/en not_active Ceased
- 2019-05-03 TW TW108115460A patent/TW202014519A/zh unknown
- 2019-05-03 JP JP2021510294A patent/JP2021522857A/ja active Pending
- 2019-05-03 CN CN201980044965.1A patent/CN112424363A/zh active Pending
- 2019-05-03 EP EP19796615.3A patent/EP3788152A4/en not_active Withdrawn
- 2019-05-03 KR KR1020207035088A patent/KR20210018273A/ko not_active Ceased
- 2019-05-03 AU AU2019262200A patent/AU2019262200A1/en not_active Abandoned
- 2019-05-06 UY UY0001038215A patent/UY38215A/es not_active Application Discontinuation
-
2020
- 2020-06-11 US US16/899,436 patent/US20200354690A1/en not_active Abandoned
-
2021
- 2021-09-08 US US17/469,648 patent/US20220002681A1/en not_active Abandoned
-
2022
- 2022-07-06 US US17/858,899 patent/US20220387531A1/en not_active Abandoned
- 2022-07-06 US US17/858,885 patent/US20220380736A1/en not_active Abandoned
- 2022-09-16 US US17/932,812 patent/US20230038106A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522857A5 (https=) | ||
| Dorscht et al. | Comparative genome analysis of Listeria bacteriophages reveals extensive mosaicism, programmed translational frameshifting, and a novel prophage insertion site | |
| JP2022127638A5 (https=) | ||
| Zimmer et al. | Genome and proteome of Listeria monocytogenes phage PSA: an unusual case for programmed+ 1 translational frameshifting in structural protein synthesis | |
| Born et al. | Novel virulent and broad-host-range Erwinia amylovora bacteriophages reveal a high degree of mosaicism and a relationship to Enterobacteriaceae phages | |
| Wang et al. | Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate | |
| Fortier et al. | Genome sequence and global gene expression of Q54, a new phage species linking the 936 and c2 phage species of Lactococcus lactis | |
| JP2016537341A5 (https=) | ||
| Erdmann et al. | SMV1 virus-induced CRISPR spacer acquisition from the conjugative plasmid pMGB1 in Sulfolobus solfataricus P2 | |
| Hertwig et al. | Sequence analysis of the genome of the temperate Yersinia enterocolitica phage PY54 | |
| Kleppen et al. | Novel Podoviridae family bacteriophage infecting Weissella cibaria isolated from Kimchi | |
| Zago et al. | Characterization of the genome of the dairy Lactobacillus helveticus bacteriophage ΦAQ113 | |
| JP2023548581A5 (https=) | ||
| Kilcher et al. | Brochothrix thermosphacta bacteriophages feature heterogeneous and highly mosaic genomes and utilize unique prophage insertion sites | |
| JP2024523367A (ja) | 広域溶解活性を有する抗菌ペプチドＰ１０４、リシンＬｙｓＰ５３及びその応用 | |
| US20230041099A1 (en) | Crispr-cas10 systems and methods for phage genome editing | |
| Jun et al. | Characterization and complete genome sequence of a novel N4-like bacteriophage, pSb-1 infecting Shigella boydii | |
| Delisle et al. | Isolation and expression of the lysis genes of Actinomyces naeslundii phage Av-1 | |
| Siboo et al. | Genomic organization and molecular characterization of SM1, a temperate bacteriophage of Streptococcus mitis | |
| Peters et al. | The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6 | |
| Wu et al. | Characterization and genomic analysis of ɸSHP3, a new transposable bacteriophage infecting Stenotrophomonas maltophilia | |
| Mahanivong et al. | Sequence analysis and molecular characterization of the Lactococcus lactis temperate bacteriophage BK5-T | |
| US20150247127A1 (en) | Bacteriophages for use against bacterial infections | |
| JP2021525105A5 (https=) | ||
| Beilstein et al. | Temperate bacteriophage ΦO18P from an Aeromonas media isolate: characterization and complete genome sequence |